XML 34 R70.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisition of CryoGene Partners - Preliminary Fair Value of Intangible Assets (Details) - USD ($)
3 Months Ended 12 Months Ended
May 14, 2019
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]                      
Annual Amortization Expense                   $ 313,300 $ 0
Goodwill   $ 10,999,722       $ 0       10,999,722 0
Business Acquisition, Transaction Costs $ 266,400                    
Revenues   9,242,000 $ 9,583,000 $ 8,464,000 $ 6,653,000 5,691,000 $ 5,285,000 $ 4,627,000 $ 4,023,000 33,941,900 19,626,453
Net Income (Loss) Attributable to Parent   (948,000) $ (12,469,000) $ (2,528,000) $ (2,387,000) $ (2,258,000) $ (2,144,000) $ (2,471,000) $ (2,683,000) (18,331,479) $ (9,555,601)
Global Bioservices [Member]                      
Business Acquisition [Line Items]                      
Goodwill   10,999,722               10,999,722  
Revenues                   3,028,555  
CryoGene Partners [Member]                      
Business Acquisition [Line Items]                      
Estimated Fair Value 5,280,000 5,280,000               5,280,000  
Annual Amortization Expense                   537,000  
Goodwill 10,999,722                    
Revenues                   3,000,000  
Net Income (Loss) Attributable to Parent                   437,100  
CryoGene Partners [Member] | Global Bioservices [Member]                      
Business Acquisition [Line Items]                      
Goodwill 11,000,000 $ 11,000,000               $ 11,000,000  
CryoGene Partners [Member] | Non-compete agreement [Member]                      
Business Acquisition [Line Items]                      
Estimated Fair Value $ 390,000                    
Estimated Useful Life 5 years                    
Annual Amortization Expense $ 78,000                    
CryoGene Partners [Member] | Technology [Member]                      
Business Acquisition [Line Items]                      
Estimated Fair Value $ 510,000                    
Estimated Useful Life 5 years                    
Annual Amortization Expense $ 102,000                    
CryoGene Partners [Member] | Customer relationships [Member]                      
Business Acquisition [Line Items]                      
Estimated Fair Value $ 3,900,000                    
Estimated Useful Life 12 years                    
Annual Amortization Expense $ 325,000                    
CryoGene Partners [Member] | Cryogene trade name/trademark                      
Business Acquisition [Line Items]                      
Estimated Fair Value $ 480,000                    
Estimated Useful Life 15 years                    
Annual Amortization Expense $ 32,000